Par Pharmaceutical says receives approval for generic Inderal-LA

Mon Jan 29, 2007 4:15am EST
 
[-] Text [+]
Co announces it has received final approval from the FDA of its Abbreviated New Drug Application for propranolol hydrochloride extended release capsules in 60-, 80-, 120- and 160 mg dosage strengths.

 

Editor's Choice

A selection of our best photos from the past 24 hours.  Slideshow 

Most Popular on Reuters

  • Articles
  • Video
Join the Reuters Consumer Insight Panel and help us get to know you better

Join the Reuters Consumer Insight Panel and help us get to know you better